at Zacks.com (Fri, 2:00PM)
Ilumina (ILMN -3.6%) slips today on a Baird dowgrade to Neutral. Baird says there are near-term...
Ilumina (ILMN -3.6%) slips today on a Baird dowgrade to Neutral. Baird says there are near-term M&A risks, specifically citing ILMN's own bid for Complete Genomics (GNOM +0.2%) while chatter resurfaces about Roche (RHHBY.OB) potentially trying to buy ILMN again after falling to reach a deal earlier this year.
From other sites
at Zacks.com (Fri, 8:46AM)
at Zacks.com (Thu, 5:50PM)
at Investor's Business Daily (Tue, 5:55PM)
at Zacks.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs